Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
Abbott (NYSE: ABT) today announced new data from two real-world studies1, 2 showing people with Type 2 diabetes using GLP-1 medicines and FreeStyle...
O teste avalia lesão cerebral traumática leve (mTBI), também conhecida como concussão, com resultado disponibilizado dentro de 18 minutos por meio de ...
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 55 cents per share. This marks the 401st consecutive...
Abbott (NYSE: ABT) today announced that the Circulatory System Devices Panel of the Medical Devices Advisory Committee for the U.S. Food and Drug...
A new study published online and available in the February print edition of the journal Transfusion shows the mixed reality technology for use during ...
The PROTALITY™ brand provides nutritional support for adults pursuing weight loss in the form of a high-protein nutrition shake featuring a blend of...
Abbott (NYSE: ABT) announced today that it received approval from the U.S. Food and Drug Administration (FDA) to launch the Liberta RC™ DBS system,...
...
Abbott's Volt™ Pulsed Field Ablation System is designed to provide a new therapy option for people battling heart rhythm disorders such as atrial...
Abbott (NYSE: ABT) will announce its fourth-quarter 2023 financial results on Wednesday, Jan. 24, before the market opens. The announcement will be...
Abbott (NYSE: ABT) will present at the 42nd annual J.P. Morgan Healthcare Conference on Tuesday, Jan. 9, 2024. Robert B. Ford, chairman and chief...
Abbott (NYSE: ABT) today announced that its board of directors has increased the company's quarterly common dividend to 55 cents per share, an...
Abbott (NYSE: ABT) announced new late-breaking data that show advanced heart failure patients living with its HeartMate 3™ heart pump who didn't...
A study of Abbott's (NYSE: ABT) Healthy Food Rx, a food as medicine program that provides home-delivered medical prescriptions of healthy food to...
Abbott (NYSE: ABT) has received U.S. Food and Drug Administration (FDA) approval for its molecular human papillomavirus or HPV screening solution,...
Abbott and Shepherd aim to raise awareness of the rising rates of diabetes diagnoses and how access to continuous glucose monitoring (CGM) systems...
Abbott (NYSE: ABT), a global leader in heart health, announced today the Abbott HeartMates program, a new initiative that will kick off with...
New survey by Morning Consult on behalf of Abbott shows student loans are having a profound and far-reaching impact on young adults and their...
Abbott's new investigational drug-eluting Esprit BTK (below-the-knee) resorbable scaffold is made of naturally dissolving material that disappears...
Abbott (NYSE: ABT) today announced data from late-breaking presentations showing the impact of its minimally invasive heart devices in treating...
Abbott (NYSE: ABT) today announced financial results for the third quarter ended Sept. 30, 2023. Third-quarter GAAP diluted EPS of $0.82 and adjusted ...
A Abbott anuncia o lançamento do seu cateter de ablação TactiFlex™, Sensor Enabled™, o primeiro cateter de ablação do mundo com uma ponta flexível e...
Abbott (NYSE: ABT) will announce its third-quarter 2023 financial results on Wednesday, Oct. 18, before the market opens. The announcement will be...
Abbott (NYSE: ABT) today announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems...
The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 51 cents per share. This marks the 399th consecutive...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.